The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The Perfect Storm of Overutilization
Abstract
The United States spends substantially more per person on health care than any other country, and yet US health outcomes are the same as or worse than those in other coutries. In 2005, the last year for which comparative statistics are available, the United States spent $6401 per person, whereas the next highest spending was in Norway and Switzerland, $4364 and $4177, respectively (TABLE). Overall, US health care expenditures are 2.4 times the average of those of all developed countries ($2759 per person), yet health outcomes for US patients, whether measured by life expectancy, disease-specific mortality rates, or other variables, are unimpressive (Table). There are many explanations for the higher costs of US health care. Because health insurance must be underwritten and sold to individual employers and self-insured individuals, administrative costs exceed $145 billion. This does not include employers’ costs for purchasing and managing employees’ health insurance. One estimate suggests that the private employer insurance market wastes more than $50 billion in administrative costs. A second factor is higher prices in the United States for important inputs to health care, such as physicians’ services, prescription drugs, and diagnostic testing. US physicians earn double the income of their peers in other industrialized countries (Table). Similarly, prices to the public for drugs in the United States are 10% to 30% higher than in other developed countries. Disparities in prices of inputs to health care account for at least $100 billion annually of higher spending in the United States. A third contributor to US costs is the abundance of amenities. Hospital rooms in the United States offer more privacy, comfort, and auxiliary services than do hospital rooms in most other countries. US physicians’ offices are typically more conveniently located and have parking nearby and more attractive waiting rooms. Overutilization of Health Care The most important contributor to the high cost of US health care, however, is overutilization. Overutilization can take 2 forms: higher volumes, such as more office visits, hospitalizations, tests, procedures, and prescriptions than are appropriate or more costly specialists, tests, procedures, and prescriptions than are appropriate. It ismorecostly care, rather thanhighvolume, that accounts for higher expenditures in the United States. The volume of services is not extreme. A hospitalization rate of 121 per 1000 US patients is higher than that of Japan (106) but considerably lower than the rate in Switzerland (157), Norway (173), and France (268) and lower than the Organisation for Economic Co-operation and Development (OECD) average (163) (Table). TheUShospitalizationrate is21stof30OECDcountries. Similarly, US patients have 3.8 physician visits annually per capita, fewer than the OECD average of 6.8. In contrast with volume, in which the United States is not the leader, there are almost 3 times as many magnetic resonance imaging scanners in the United States as the OECD average, higher only in Japan. US patients receive considerably more cardiac revascularization procedures (579 per 100 000 population)—coronary artery bypass grafts, angioplasties, and stents—45% more than patients in Norway, the country with the next highest number (Table). The United States has the fourth highest per capita consumption of pharmaceuticals. US patients utilize many more “new drugs”— those on the market 5 years or fewer—than patients in other countries. For instance, ezetimibe, which decreases lowdensity lipoprotein cholesterol level and was approved in October 2002, is not recommended by major guidelines as first-line therapy. Nevertheless, the use of ezetimibe in the United States is about 5 times higher than it is in Canada, constituting more than 15% of prescriptions for lipidlowering agents. Greater use of new, more expensive pharmaceuticals, as well as higher prices both for older and newer drugs, helps explain why the United States spent $752 per capita (2005) on drugs, whereas France, with the next highest expenditure, spent $559 and Japan just $425.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Do Doctors Practice Defensive Medicine?
Kessler, D., & McClellan, M. (1996) · The Quarterly Journal of Economics · doi:10.2307/2946682 · Cited by 615
International Prices And Availability Of Pharmaceuticals In 2005
Danzon, P. M., & Furukawa, M. F. (2008) · Health Affairs · doi:10.1377/hlthaff.27.1.221 · Cited by 170
American College of Physicians* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-1-200801010-00196 · Cited by 151
Use of Ezetimibe in the United States and Canada
Jackevicius, C. A., Tu, J. V., Ross, J. S., Ko, D. T., & Krumholz, H. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0801461 · Cited by 92
The U.S. Health Care Spending: Comparison With Other OECD Countries
Peterson, C. L., & Burton, R. A. (2008) · University of North Texas Digital Library (University of North Texas) · Cited by 61
What Cannot Be Said on Television About Health Care
Emanuel, E. J. (2007) · JAMA · doi:10.1001/jama.297.19.2131 · Cited by 20
Self-citation
Cited by
Evidence for overuse of medical services around the world
Brownlee, S., Chalkidou, K., Doust, J., Elshaug, A. G., Glasziou, P., Heath, I., Nagpal, S., Saini, V., Srivastava, D., Chalmers, K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32585-5 · Cited by 1,149
Hoffmann, T. C., & Del Mar, C. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6016 · Cited by 707
Addressing Overutilization in Medical Imaging
Hendee, W. R., Becker, G. J., Borgstede, J. P., Bosma, J., Casarella, W. J., Erickson, B. A., Maynard, C. D., Thrall, J. H., & Wallner, P. E. (2010) · Radiology · doi:10.1148/radiol.10100063 · Cited by 619
Kass, N. E., Faden, R. R., Goodman, S. N., Pronovost, P., Tunis, S., & Beauchamp, T. L. (2013) · Hastings Center Report · doi:10.1002/hast.133 · Cited by 235
Anxiety disorders and healthcare utilization: A systematic review
Horenstein, A., & Heimberg, R. G. (2020) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101894 · Cited by 183
Metadata
- Authors
- Emanuel, E. J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-06-18
- Volume
- 299
- Issue
- 23
- Pages
- 2789
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2006982272
- Cited by
- 390
- References
- 7
- FWCI
- 41.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Perfect Storm of Overutilization. https://app.cochat.ai/papers/10.1001/jama.299.23.2789
- The paper
- Emanuel, E. J. (2008). The Perfect Storm of Overutilization. JAMA. https://doi.org/10.1001/jama.299.23.2789
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.